Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s Stelara
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
This is how dependent Germany is on Chinese medicines
Whether it’s painkillers, antibiotics, or diabetes medication, German pharmacies can hardly do without medicines made in China. Many…
Is Your Medication Made in a Contaminated Factory? The FDA Won’t Tell You
ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like…
Novo Nordisk board members step down after major shareholder dispute
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
What will TrumpRx mean for patients? Who saves — and how much
Could “TrumpRx” be the prescription for lower drug prices? President Donald Trump announced a landmark deal with Pfizer…
AstraZeneca to list shares in New York while keeping London listing
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Investors of India’s generic drugmakers rattled
MUMBAI, INDIA – MARCH 3: A technician works at a Cipla laboratory March 3, 2002 in Vikhrohi, Mumbai,…
Natural Plant Compound Shows Promise for Treating Gum Disease
A natural compound called morin, found in fruits, teas, and nuts, is showing promise as a new tool…
EU Panel Recommends Tezspire for CRwNP | RT
AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult…